Connor, Clark & Lunn Investment Management Ltd. Aurinia Pharmaceuticals Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $28.9 Billion
  • Q3 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 541,188 shares of AUPH stock, worth $8.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
541,188
Previous 650,191 16.76%
Holding current value
$8.31 Million
Previous $5.51 Million 8.59%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$7.47 - $13.14 $814,252 - $1.43 Million
-109,003 Reduced 16.76%
541,188 $5.98 Million
Q2 2025

Aug 07, 2025
SELL
$7.2 - $8.64 $691,473 - $829,768
-96,038 Reduced 12.87%
650,191 $5.51 Million
Q1 2025

May 12, 2025
BUY
$7.55 - $8.77 $1.43 Million - $1.66 Million
189,775 Added 34.1%
746,229 $6 Million
Q4 2024

Feb 10, 2025
BUY
$6.75 - $10.44 $689,816 - $1.07 Million
102,195 Added 22.5%
556,454 $5 Million
Q3 2024

Nov 08, 2024
BUY
$5.32 - $7.33 $2.42 Million - $3.33 Million
454,259 New
454,259 $3.33 Million
Q3 2021

Nov 12, 2021
SELL
$10.93 - $23.55 $4.01 Million - $8.64 Million
-367,000 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$10.0 - $14.52 $689,120 - $1 Million
-68,912 Reduced 15.81%
367,000 $4.76 Million
Q1 2021

May 13, 2021
SELL
$12.3 - $18.73 $19.2 Million - $29.3 Million
-1,564,060 Reduced 78.2%
435,912 $5.67 Million
Q4 2020

Feb 16, 2021
BUY
$12.94 - $16.05 $4.91 Million - $6.09 Million
379,280 Added 23.4%
1,999,972 $27.6 Million
Q3 2020

Nov 12, 2020
BUY
$13.19 - $16.66 $2.2 Million - $2.78 Million
166,792 Added 11.47%
1,620,692 $23.9 Million
Q2 2020

Aug 13, 2020
BUY
$14.12 - $18.33 $5.31 Million - $6.9 Million
376,330 Added 34.92%
1,453,900 $23.6 Million
Q1 2020

May 13, 2020
BUY
$11.34 - $21.46 $12.2 Million - $23.1 Million
1,077,570 New
1,077,570 $15.6 Million

Others Institutions Holding AUPH

# of Institutions
269
Shares Held
69.3M
Call Options Held
984K
Put Options Held
574K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email